Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties

Farnesyl Protein transferase inhibitors with in vivo radiosensitizing properties

US Patent 6545020 · Granted Apr 8, 2003

Estimated economic value: $189,667,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer2012
Farnesyl transferase inhibiting 1,2-annelated quinoline enantiomer2012
Substituted 2-alkyl quinazolinone derivatives as PARP inhibitors2011
Triazoles as farnesyl transferase inhibitors2009
Triazoles as farnesyl transferase inhibitors2009
Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smoo2007
Triazoles as farnesyl transferase inhibitors2006
Dosing regimen2005
Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smoo2004
Method of use of (imidazol-5-yl)methyl-2-quinolinone derivatives to inhibit smoo2004
Farnesyl protein transferase inhibitors for treating arthropathies2002
(Imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle c2002